Anticancer effects of folic acid-functionalized covalent organic framework containing doxorubicin on SW480 colon cancer cells: a promising tool for drug targeted delivery Article Swipe
Razie Ezati
,
Behrooz Johari
,
Jaber Yousefi Seyf
,
Yousef Mortazavi
,
Mehdi Azizi
,
Hadi Samadian
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1186/s12896-025-01027-8
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1186/s12896-025-01027-8
Colorectal cancer is one of the deadliest forms of gastrointestinal cancer, with conventional treatments often facing significant limitations. As a result, new approaches, particularly in targeted drug delivery, have shown great promise. In this study, the COF-FA@DOX nanocarrier was developed, where covalent organic frameworks (COFs) were functionalized with folic acid (FA) and then loaded with Doxorubicin (DOX). The as-synthesized COF-FA@DOX nanocarrier was characterized using different techniques. To assess its anticancer effectiveness, MTT, flow cytometry, and scratch assays were conducted on SW480 and HUVEC cells to examine cell viability, cellular uptake, cell cycle progression, apoptosis, and cell migration, respectively. The obtained results demonstrated that the COF-FA@DOX nanocarrier was efficiently internalized by cancer cells and showed significantly higher cytotoxicity compared to other synthesized nanocarrier groups and free DOX drug. Moreover, the COF-FA@DOX nanocarrier caused cell cycle arrest, induced apoptosis, and inhibited cell migration at lower doses than the free DOX drug. Altogether, these findings suggest that the COF-FA@DOX nanocarrier is an effective and promising drug delivery system for DOX in colorectal cancer, potentially enhancing the therapeutic efficacy of DOX drug while minimizing side effects through targeted delivery. Further investigation is required to assess their efficacy in vivo and discover potential clinical applications.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1186/s12896-025-01027-8
- https://bmcbiotechnol.biomedcentral.com/counter/pdf/10.1186/s12896-025-01027-8
- OA Status
- gold
- References
- 54
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4413764645
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4413764645Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1186/s12896-025-01027-8Digital Object Identifier
- Title
-
Anticancer effects of folic acid-functionalized covalent organic framework containing doxorubicin on SW480 colon cancer cells: a promising tool for drug targeted deliveryWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-08-27Full publication date if available
- Authors
-
Razie Ezati, Behrooz Johari, Jaber Yousefi Seyf, Yousef Mortazavi, Mehdi Azizi, Hadi SamadianList of authors in order
- Landing page
-
https://doi.org/10.1186/s12896-025-01027-8Publisher landing page
- PDF URL
-
https://bmcbiotechnol.biomedcentral.com/counter/pdf/10.1186/s12896-025-01027-8Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://bmcbiotechnol.biomedcentral.com/counter/pdf/10.1186/s12896-025-01027-8Direct OA link when available
- Concepts
-
Biology, Doxorubicin, Targeted drug delivery, Folic acid, Drug delivery, Pharmacology, Drug, Colorectal cancer, Cancer, Cancer research, Combinatorial chemistry, Biochemistry, Nanotechnology, Materials science, Chemotherapy, Internal medicine, Chemistry, Genetics, MedicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
54Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4413764645 |
|---|---|
| doi | https://doi.org/10.1186/s12896-025-01027-8 |
| ids.doi | https://doi.org/10.1186/s12896-025-01027-8 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40866979 |
| ids.openalex | https://openalex.org/W4413764645 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | Q000494 |
| mesh[0].descriptor_ui | D004317 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | pharmacology |
| mesh[0].descriptor_name | Doxorubicin |
| mesh[1].qualifier_ui | Q000737 |
| mesh[1].descriptor_ui | D004317 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | chemistry |
| mesh[1].descriptor_name | Doxorubicin |
| mesh[2].qualifier_ui | Q000008 |
| mesh[2].descriptor_ui | D004317 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | administration & dosage |
| mesh[2].descriptor_name | Doxorubicin |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D006801 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Humans |
| mesh[4].qualifier_ui | Q000737 |
| mesh[4].descriptor_ui | D005492 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | chemistry |
| mesh[4].descriptor_name | Folic Acid |
| mesh[5].qualifier_ui | Q000187 |
| mesh[5].descriptor_ui | D017209 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | drug effects |
| mesh[5].descriptor_name | Apoptosis |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D045744 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Cell Line, Tumor |
| mesh[7].qualifier_ui | Q000188 |
| mesh[7].descriptor_ui | D003110 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | drug therapy |
| mesh[7].descriptor_name | Colonic Neoplasms |
| mesh[8].qualifier_ui | Q000379 |
| mesh[8].descriptor_ui | D016503 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | methods |
| mesh[8].descriptor_name | Drug Delivery Systems |
| mesh[9].qualifier_ui | Q000187 |
| mesh[9].descriptor_ui | D002470 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | drug effects |
| mesh[9].descriptor_name | Cell Survival |
| mesh[10].qualifier_ui | Q000187 |
| mesh[10].descriptor_ui | D002465 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | drug effects |
| mesh[10].descriptor_name | Cell Movement |
| mesh[11].qualifier_ui | Q000494 |
| mesh[11].descriptor_ui | D000970 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | pharmacology |
| mesh[11].descriptor_name | Antineoplastic Agents |
| mesh[12].qualifier_ui | Q000737 |
| mesh[12].descriptor_ui | D000970 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | chemistry |
| mesh[12].descriptor_name | Antineoplastic Agents |
| mesh[13].qualifier_ui | Q000737 |
| mesh[13].descriptor_ui | D004337 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | chemistry |
| mesh[13].descriptor_name | Drug Carriers |
| mesh[14].qualifier_ui | Q000737 |
| mesh[14].descriptor_ui | D000073396 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | chemistry |
| mesh[14].descriptor_name | Metal-Organic Frameworks |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D061307 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Human Umbilical Vein Endothelial Cells |
| type | article |
| title | Anticancer effects of folic acid-functionalized covalent organic framework containing doxorubicin on SW480 colon cancer cells: a promising tool for drug targeted delivery |
| biblio.issue | 1 |
| biblio.volume | 25 |
| biblio.last_page | 91 |
| biblio.first_page | 91 |
| grants[0].funder | https://openalex.org/F4320325027 |
| grants[0].award_id | Grant Number: A-12-1244-26 & Ethical Code: IR.ZUMS.BLC.1402.029 |
| grants[0].funder_display_name | Zanjan University of Medical Sciences |
| topics[0].id | https://openalex.org/T10096 |
| topics[0].field.id | https://openalex.org/fields/16 |
| topics[0].field.display_name | Chemistry |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/3 |
| topics[0].domain.display_name | Physical Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1604 |
| topics[0].subfield.display_name | Inorganic Chemistry |
| topics[0].display_name | Metal-Organic Frameworks: Synthesis and Applications |
| topics[1].id | https://openalex.org/T12038 |
| topics[1].field.id | https://openalex.org/fields/25 |
| topics[1].field.display_name | Materials Science |
| topics[1].score | 0.9994000196456909 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2505 |
| topics[1].subfield.display_name | Materials Chemistry |
| topics[1].display_name | Covalent Organic Framework Applications |
| topics[2].id | https://openalex.org/T10782 |
| topics[2].field.id | https://openalex.org/fields/22 |
| topics[2].field.display_name | Engineering |
| topics[2].score | 0.996999979019165 |
| topics[2].domain.id | https://openalex.org/domains/3 |
| topics[2].domain.display_name | Physical Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2204 |
| topics[2].subfield.display_name | Biomedical Engineering |
| topics[2].display_name | Nanoplatforms for cancer theranostics |
| funders[0].id | https://openalex.org/F4320325027 |
| funders[0].ror | https://ror.org/01xf7jb19 |
| funders[0].display_name | Zanjan University of Medical Sciences |
| is_xpac | False |
| apc_list.value | 1570 |
| apc_list.currency | GBP |
| apc_list.value_usd | 1925 |
| apc_paid.value | 1570 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 1925 |
| concepts[0].id | https://openalex.org/C86803240 |
| concepts[0].level | 0 |
| concepts[0].score | 0.6897302865982056 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[0].display_name | Biology |
| concepts[1].id | https://openalex.org/C2781303535 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6540732979774475 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q18936 |
| concepts[1].display_name | Doxorubicin |
| concepts[2].id | https://openalex.org/C126511603 |
| concepts[2].level | 3 |
| concepts[2].score | 0.607068657875061 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1261145 |
| concepts[2].display_name | Targeted drug delivery |
| concepts[3].id | https://openalex.org/C2992130864 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6068680286407471 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q127060 |
| concepts[3].display_name | Folic acid |
| concepts[4].id | https://openalex.org/C2779820397 |
| concepts[4].level | 2 |
| concepts[4].score | 0.562667965888977 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1392806 |
| concepts[4].display_name | Drug delivery |
| concepts[5].id | https://openalex.org/C98274493 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5178945064544678 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[5].display_name | Pharmacology |
| concepts[6].id | https://openalex.org/C2780035454 |
| concepts[6].level | 2 |
| concepts[6].score | 0.498748779296875 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[6].display_name | Drug |
| concepts[7].id | https://openalex.org/C526805850 |
| concepts[7].level | 3 |
| concepts[7].score | 0.49800610542297363 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q188874 |
| concepts[7].display_name | Colorectal cancer |
| concepts[8].id | https://openalex.org/C121608353 |
| concepts[8].level | 2 |
| concepts[8].score | 0.42378729581832886 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[8].display_name | Cancer |
| concepts[9].id | https://openalex.org/C502942594 |
| concepts[9].level | 1 |
| concepts[9].score | 0.41738882660865784 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[9].display_name | Cancer research |
| concepts[10].id | https://openalex.org/C21951064 |
| concepts[10].level | 1 |
| concepts[10].score | 0.335175096988678 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q899212 |
| concepts[10].display_name | Combinatorial chemistry |
| concepts[11].id | https://openalex.org/C55493867 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3261949419975281 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[11].display_name | Biochemistry |
| concepts[12].id | https://openalex.org/C171250308 |
| concepts[12].level | 1 |
| concepts[12].score | 0.26314109563827515 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11468 |
| concepts[12].display_name | Nanotechnology |
| concepts[13].id | https://openalex.org/C192562407 |
| concepts[13].level | 0 |
| concepts[13].score | 0.17057976126670837 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q228736 |
| concepts[13].display_name | Materials science |
| concepts[14].id | https://openalex.org/C2776694085 |
| concepts[14].level | 2 |
| concepts[14].score | 0.1580578088760376 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[14].display_name | Chemotherapy |
| concepts[15].id | https://openalex.org/C126322002 |
| concepts[15].level | 1 |
| concepts[15].score | 0.10835963487625122 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[15].display_name | Internal medicine |
| concepts[16].id | https://openalex.org/C185592680 |
| concepts[16].level | 0 |
| concepts[16].score | 0.09600505232810974 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[16].display_name | Chemistry |
| concepts[17].id | https://openalex.org/C54355233 |
| concepts[17].level | 1 |
| concepts[17].score | 0.07838952541351318 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[17].display_name | Genetics |
| concepts[18].id | https://openalex.org/C71924100 |
| concepts[18].level | 0 |
| concepts[18].score | 0.07803228497505188 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[18].display_name | Medicine |
| keywords[0].id | https://openalex.org/keywords/biology |
| keywords[0].score | 0.6897302865982056 |
| keywords[0].display_name | Biology |
| keywords[1].id | https://openalex.org/keywords/doxorubicin |
| keywords[1].score | 0.6540732979774475 |
| keywords[1].display_name | Doxorubicin |
| keywords[2].id | https://openalex.org/keywords/targeted-drug-delivery |
| keywords[2].score | 0.607068657875061 |
| keywords[2].display_name | Targeted drug delivery |
| keywords[3].id | https://openalex.org/keywords/folic-acid |
| keywords[3].score | 0.6068680286407471 |
| keywords[3].display_name | Folic acid |
| keywords[4].id | https://openalex.org/keywords/drug-delivery |
| keywords[4].score | 0.562667965888977 |
| keywords[4].display_name | Drug delivery |
| keywords[5].id | https://openalex.org/keywords/pharmacology |
| keywords[5].score | 0.5178945064544678 |
| keywords[5].display_name | Pharmacology |
| keywords[6].id | https://openalex.org/keywords/drug |
| keywords[6].score | 0.498748779296875 |
| keywords[6].display_name | Drug |
| keywords[7].id | https://openalex.org/keywords/colorectal-cancer |
| keywords[7].score | 0.49800610542297363 |
| keywords[7].display_name | Colorectal cancer |
| keywords[8].id | https://openalex.org/keywords/cancer |
| keywords[8].score | 0.42378729581832886 |
| keywords[8].display_name | Cancer |
| keywords[9].id | https://openalex.org/keywords/cancer-research |
| keywords[9].score | 0.41738882660865784 |
| keywords[9].display_name | Cancer research |
| keywords[10].id | https://openalex.org/keywords/combinatorial-chemistry |
| keywords[10].score | 0.335175096988678 |
| keywords[10].display_name | Combinatorial chemistry |
| keywords[11].id | https://openalex.org/keywords/biochemistry |
| keywords[11].score | 0.3261949419975281 |
| keywords[11].display_name | Biochemistry |
| keywords[12].id | https://openalex.org/keywords/nanotechnology |
| keywords[12].score | 0.26314109563827515 |
| keywords[12].display_name | Nanotechnology |
| keywords[13].id | https://openalex.org/keywords/materials-science |
| keywords[13].score | 0.17057976126670837 |
| keywords[13].display_name | Materials science |
| keywords[14].id | https://openalex.org/keywords/chemotherapy |
| keywords[14].score | 0.1580578088760376 |
| keywords[14].display_name | Chemotherapy |
| keywords[15].id | https://openalex.org/keywords/internal-medicine |
| keywords[15].score | 0.10835963487625122 |
| keywords[15].display_name | Internal medicine |
| keywords[16].id | https://openalex.org/keywords/chemistry |
| keywords[16].score | 0.09600505232810974 |
| keywords[16].display_name | Chemistry |
| keywords[17].id | https://openalex.org/keywords/genetics |
| keywords[17].score | 0.07838952541351318 |
| keywords[17].display_name | Genetics |
| keywords[18].id | https://openalex.org/keywords/medicine |
| keywords[18].score | 0.07803228497505188 |
| keywords[18].display_name | Medicine |
| language | en |
| locations[0].id | doi:10.1186/s12896-025-01027-8 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S53489610 |
| locations[0].source.issn | 1472-6750 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1472-6750 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | BMC Biotechnology |
| locations[0].source.host_organization | https://openalex.org/P4310320256 |
| locations[0].source.host_organization_name | BioMed Central |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320256 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://bmcbiotechnol.biomedcentral.com/counter/pdf/10.1186/s12896-025-01027-8 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | BMC Biotechnology |
| locations[0].landing_page_url | https://doi.org/10.1186/s12896-025-01027-8 |
| locations[1].id | pmid:40866979 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | BMC biotechnology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40866979 |
| locations[2].id | pmh:oai:doaj.org/article:3c38621542e2418a8d87c422f8071a16 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | BMC Biotechnology, Vol 25, Iss 1, Pp 1-21 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/3c38621542e2418a8d87c422f8071a16 |
| locations[3].id | pmh:oai:europepmc.org:11190624 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400806 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Europe PMC (PubMed Central) |
| locations[3].source.host_organization | https://openalex.org/I1303153112 |
| locations[3].source.host_organization_name | European Bioinformatics Institute |
| locations[3].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12382180 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5025400400 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5602-179X |
| authorships[0].author.display_name | Razie Ezati |
| authorships[0].countries | IR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I116768543 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran |
| authorships[0].institutions[0].id | https://openalex.org/I116768543 |
| authorships[0].institutions[0].ror | https://ror.org/01xf7jb19 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I116768543 |
| authorships[0].institutions[0].country_code | IR |
| authorships[0].institutions[0].display_name | Zanjan University of Medical Sciences |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Razie Ezati |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran |
| authorships[1].author.id | https://openalex.org/A5033333376 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-3440-572X |
| authorships[1].author.display_name | Behrooz Johari |
| authorships[1].countries | IR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I116768543, https://openalex.org/I4210088961 |
| authorships[1].affiliations[0].raw_affiliation_string | Zanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran |
| authorships[1].institutions[0].id | https://openalex.org/I4210088961 |
| authorships[1].institutions[0].ror | https://ror.org/013t96v18 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I163205636, https://openalex.org/I4210088961 |
| authorships[1].institutions[0].country_code | IR |
| authorships[1].institutions[0].display_name | Biotechnology Research Center |
| authorships[1].institutions[1].id | https://openalex.org/I116768543 |
| authorships[1].institutions[1].ror | https://ror.org/01xf7jb19 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I116768543 |
| authorships[1].institutions[1].country_code | IR |
| authorships[1].institutions[1].display_name | Zanjan University of Medical Sciences |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Behrooz Johari |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Zanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran |
| authorships[2].author.id | https://openalex.org/A5013599027 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-5624-1127 |
| authorships[2].author.display_name | Jaber Yousefi Seyf |
| authorships[2].countries | IR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210107186 |
| authorships[2].affiliations[0].raw_affiliation_string | Chemical Engineering Department, Hamedan University of Technology, Hamedan, Iran |
| authorships[2].institutions[0].id | https://openalex.org/I4210107186 |
| authorships[2].institutions[0].ror | https://ror.org/01hgb6e08 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210107186 |
| authorships[2].institutions[0].country_code | IR |
| authorships[2].institutions[0].display_name | Hamedan University of Technology |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Jaber Yousefi Seyf |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Chemical Engineering Department, Hamedan University of Technology, Hamedan, Iran |
| authorships[3].author.id | https://openalex.org/A5090072813 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-4003-9618 |
| authorships[3].author.display_name | Yousef Mortazavi |
| authorships[3].countries | IR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I116768543 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran |
| authorships[3].institutions[0].id | https://openalex.org/I116768543 |
| authorships[3].institutions[0].ror | https://ror.org/01xf7jb19 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I116768543 |
| authorships[3].institutions[0].country_code | IR |
| authorships[3].institutions[0].display_name | Zanjan University of Medical Sciences |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Yousef Mortazavi |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran |
| authorships[4].author.id | https://openalex.org/A5107945441 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Mehdi Azizi |
| authorships[4].countries | IR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I112312016 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Hamadan University of Medical Sciences, Hamadan, Iran |
| authorships[4].institutions[0].id | https://openalex.org/I112312016 |
| authorships[4].institutions[0].ror | https://ror.org/02ekfbp48 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I112312016 |
| authorships[4].institutions[0].country_code | IR |
| authorships[4].institutions[0].display_name | Hamedan University of Medical Sciences |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Mehdi Azizi |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Hamadan University of Medical Sciences, Hamadan, Iran |
| authorships[5].author.id | https://openalex.org/A5023069281 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-2478-5709 |
| authorships[5].author.display_name | Hadi Samadian |
| authorships[5].countries | IR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I112312016 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Hamadan University of Medical Sciences, Hamadan, Iran |
| authorships[5].institutions[0].id | https://openalex.org/I112312016 |
| authorships[5].institutions[0].ror | https://ror.org/02ekfbp48 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I112312016 |
| authorships[5].institutions[0].country_code | IR |
| authorships[5].institutions[0].display_name | Hamedan University of Medical Sciences |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Hadi Samadian |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Hamadan University of Medical Sciences, Hamadan, Iran |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://bmcbiotechnol.biomedcentral.com/counter/pdf/10.1186/s12896-025-01027-8 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Anticancer effects of folic acid-functionalized covalent organic framework containing doxorubicin on SW480 colon cancer cells: a promising tool for drug targeted delivery |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10096 |
| primary_topic.field.id | https://openalex.org/fields/16 |
| primary_topic.field.display_name | Chemistry |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/3 |
| primary_topic.domain.display_name | Physical Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1604 |
| primary_topic.subfield.display_name | Inorganic Chemistry |
| primary_topic.display_name | Metal-Organic Frameworks: Synthesis and Applications |
| related_works | https://openalex.org/W3157244191, https://openalex.org/W4361283779, https://openalex.org/W1991750263, https://openalex.org/W2066459637, https://openalex.org/W2013980844, https://openalex.org/W3205983928, https://openalex.org/W2310386210, https://openalex.org/W2186824132, https://openalex.org/W3041384410, https://openalex.org/W3175446854 |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1186/s12896-025-01027-8 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S53489610 |
| best_oa_location.source.issn | 1472-6750 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1472-6750 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | BMC Biotechnology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320256 |
| best_oa_location.source.host_organization_name | BioMed Central |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320256 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://bmcbiotechnol.biomedcentral.com/counter/pdf/10.1186/s12896-025-01027-8 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | BMC Biotechnology |
| best_oa_location.landing_page_url | https://doi.org/10.1186/s12896-025-01027-8 |
| primary_location.id | doi:10.1186/s12896-025-01027-8 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S53489610 |
| primary_location.source.issn | 1472-6750 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1472-6750 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | BMC Biotechnology |
| primary_location.source.host_organization | https://openalex.org/P4310320256 |
| primary_location.source.host_organization_name | BioMed Central |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320256 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://bmcbiotechnol.biomedcentral.com/counter/pdf/10.1186/s12896-025-01027-8 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | BMC Biotechnology |
| primary_location.landing_page_url | https://doi.org/10.1186/s12896-025-01027-8 |
| publication_date | 2025-08-27 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4394879925, https://openalex.org/W4220871154, https://openalex.org/W2004955567, https://openalex.org/W2168015221, https://openalex.org/W4392111318, https://openalex.org/W2106926141, https://openalex.org/W3044177990, https://openalex.org/W2029938510, https://openalex.org/W4405284819, https://openalex.org/W2912561835, https://openalex.org/W2989747853, https://openalex.org/W2087813165, https://openalex.org/W3103886922, https://openalex.org/W2845838257, https://openalex.org/W3093593243, https://openalex.org/W4376132580, https://openalex.org/W4392396309, https://openalex.org/W2095805867, https://openalex.org/W4388712461, https://openalex.org/W4304989339, https://openalex.org/W4400315980, https://openalex.org/W4399117900, https://openalex.org/W4388933417, https://openalex.org/W3193240288, https://openalex.org/W2074143630, https://openalex.org/W4308292652, https://openalex.org/W2152449875, https://openalex.org/W2963891622, https://openalex.org/W2165931929, https://openalex.org/W4400087457, https://openalex.org/W2898106647, https://openalex.org/W2313006027, https://openalex.org/W1576526650, https://openalex.org/W3118081315, https://openalex.org/W4382699181, https://openalex.org/W4313398891, https://openalex.org/W4393114726, https://openalex.org/W4293569819, https://openalex.org/W2052886839, https://openalex.org/W2751656105, https://openalex.org/W3033670854, https://openalex.org/W2603499349, https://openalex.org/W4313532543, https://openalex.org/W4295079119, https://openalex.org/W2648418320, https://openalex.org/W4295292861, https://openalex.org/W2535903850, https://openalex.org/W2776231048, https://openalex.org/W4321372972, https://openalex.org/W2998075813, https://openalex.org/W2799538369, https://openalex.org/W4399149498, https://openalex.org/W2022715137, https://openalex.org/W4401395014 |
| referenced_works_count | 54 |
| abstract_inverted_index.a | 19 |
| abstract_inverted_index.As | 18 |
| abstract_inverted_index.In | 32 |
| abstract_inverted_index.To | 66 |
| abstract_inverted_index.an | 158 |
| abstract_inverted_index.at | 141 |
| abstract_inverted_index.by | 109 |
| abstract_inverted_index.in | 24, 167, 193 |
| abstract_inverted_index.is | 2, 157, 187 |
| abstract_inverted_index.of | 4, 8, 175 |
| abstract_inverted_index.on | 79 |
| abstract_inverted_index.to | 84, 118, 189 |
| abstract_inverted_index.DOX | 125, 147, 166, 176 |
| abstract_inverted_index.The | 57, 98 |
| abstract_inverted_index.and | 51, 74, 81, 94, 112, 123, 137, 160, 195 |
| abstract_inverted_index.for | 165 |
| abstract_inverted_index.its | 68 |
| abstract_inverted_index.new | 21 |
| abstract_inverted_index.one | 3 |
| abstract_inverted_index.the | 5, 35, 103, 128, 145, 154, 172 |
| abstract_inverted_index.was | 38, 61, 106 |
| abstract_inverted_index.(FA) | 50 |
| abstract_inverted_index.MTT, | 71 |
| abstract_inverted_index.acid | 49 |
| abstract_inverted_index.cell | 86, 90, 95, 132, 139 |
| abstract_inverted_index.drug | 26, 162, 177 |
| abstract_inverted_index.flow | 72 |
| abstract_inverted_index.free | 124, 146 |
| abstract_inverted_index.have | 28 |
| abstract_inverted_index.side | 180 |
| abstract_inverted_index.than | 144 |
| abstract_inverted_index.that | 102, 153 |
| abstract_inverted_index.then | 52 |
| abstract_inverted_index.this | 33 |
| abstract_inverted_index.vivo | 194 |
| abstract_inverted_index.were | 45, 77 |
| abstract_inverted_index.with | 11, 47, 54 |
| abstract_inverted_index.HUVEC | 82 |
| abstract_inverted_index.SW480 | 80 |
| abstract_inverted_index.cells | 83, 111 |
| abstract_inverted_index.cycle | 91, 133 |
| abstract_inverted_index.doses | 143 |
| abstract_inverted_index.drug. | 126, 148 |
| abstract_inverted_index.folic | 48 |
| abstract_inverted_index.forms | 7 |
| abstract_inverted_index.great | 30 |
| abstract_inverted_index.lower | 142 |
| abstract_inverted_index.often | 14 |
| abstract_inverted_index.other | 119 |
| abstract_inverted_index.shown | 29 |
| abstract_inverted_index.their | 191 |
| abstract_inverted_index.these | 150 |
| abstract_inverted_index.using | 63 |
| abstract_inverted_index.where | 40 |
| abstract_inverted_index.while | 178 |
| abstract_inverted_index.(COFs) | 44 |
| abstract_inverted_index.(DOX). | 56 |
| abstract_inverted_index.assays | 76 |
| abstract_inverted_index.assess | 67, 190 |
| abstract_inverted_index.cancer | 1, 110 |
| abstract_inverted_index.caused | 131 |
| abstract_inverted_index.facing | 15 |
| abstract_inverted_index.groups | 122 |
| abstract_inverted_index.higher | 115 |
| abstract_inverted_index.loaded | 53 |
| abstract_inverted_index.showed | 113 |
| abstract_inverted_index.study, | 34 |
| abstract_inverted_index.system | 164 |
| abstract_inverted_index.Further | 185 |
| abstract_inverted_index.arrest, | 134 |
| abstract_inverted_index.cancer, | 10, 169 |
| abstract_inverted_index.effects | 181 |
| abstract_inverted_index.examine | 85 |
| abstract_inverted_index.induced | 135 |
| abstract_inverted_index.organic | 42 |
| abstract_inverted_index.result, | 20 |
| abstract_inverted_index.results | 100 |
| abstract_inverted_index.scratch | 75 |
| abstract_inverted_index.suggest | 152 |
| abstract_inverted_index.through | 182 |
| abstract_inverted_index.uptake, | 89 |
| abstract_inverted_index.cellular | 88 |
| abstract_inverted_index.clinical | 198 |
| abstract_inverted_index.compared | 117 |
| abstract_inverted_index.covalent | 41 |
| abstract_inverted_index.delivery | 163 |
| abstract_inverted_index.discover | 196 |
| abstract_inverted_index.efficacy | 174, 192 |
| abstract_inverted_index.findings | 151 |
| abstract_inverted_index.obtained | 99 |
| abstract_inverted_index.promise. | 31 |
| abstract_inverted_index.required | 188 |
| abstract_inverted_index.targeted | 25, 183 |
| abstract_inverted_index.Moreover, | 127 |
| abstract_inverted_index.conducted | 78 |
| abstract_inverted_index.deadliest | 6 |
| abstract_inverted_index.delivery, | 27 |
| abstract_inverted_index.delivery. | 184 |
| abstract_inverted_index.different | 64 |
| abstract_inverted_index.effective | 159 |
| abstract_inverted_index.enhancing | 171 |
| abstract_inverted_index.inhibited | 138 |
| abstract_inverted_index.migration | 140 |
| abstract_inverted_index.potential | 197 |
| abstract_inverted_index.promising | 161 |
| abstract_inverted_index.COF-FA@DOX | 36, 59, 104, 129, 155 |
| abstract_inverted_index.Colorectal | 0 |
| abstract_inverted_index.anticancer | 69 |
| abstract_inverted_index.apoptosis, | 93, 136 |
| abstract_inverted_index.colorectal | 168 |
| abstract_inverted_index.cytometry, | 73 |
| abstract_inverted_index.developed, | 39 |
| abstract_inverted_index.frameworks | 43 |
| abstract_inverted_index.migration, | 96 |
| abstract_inverted_index.minimizing | 179 |
| abstract_inverted_index.treatments | 13 |
| abstract_inverted_index.viability, | 87 |
| abstract_inverted_index.Altogether, | 149 |
| abstract_inverted_index.Doxorubicin | 55 |
| abstract_inverted_index.approaches, | 22 |
| abstract_inverted_index.efficiently | 107 |
| abstract_inverted_index.nanocarrier | 37, 60, 105, 121, 130, 156 |
| abstract_inverted_index.potentially | 170 |
| abstract_inverted_index.significant | 16 |
| abstract_inverted_index.synthesized | 120 |
| abstract_inverted_index.techniques. | 65 |
| abstract_inverted_index.therapeutic | 173 |
| abstract_inverted_index.conventional | 12 |
| abstract_inverted_index.cytotoxicity | 116 |
| abstract_inverted_index.demonstrated | 101 |
| abstract_inverted_index.internalized | 108 |
| abstract_inverted_index.limitations. | 17 |
| abstract_inverted_index.particularly | 23 |
| abstract_inverted_index.progression, | 92 |
| abstract_inverted_index.applications. | 199 |
| abstract_inverted_index.characterized | 62 |
| abstract_inverted_index.investigation | 186 |
| abstract_inverted_index.respectively. | 97 |
| abstract_inverted_index.significantly | 114 |
| abstract_inverted_index.as-synthesized | 58 |
| abstract_inverted_index.effectiveness, | 70 |
| abstract_inverted_index.functionalized | 46 |
| abstract_inverted_index.gastrointestinal | 9 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5033333376 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| corresponding_institution_ids | https://openalex.org/I116768543, https://openalex.org/I4210088961 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6299999952316284 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.37333005 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |